HER2 Support Group Forums - View Single Post - BioSante Pharmaceuticals receives receipt of Orphan Drug designation for GVAX Pancrea

News · 03-15-2010, 05:21 AM

BioSante Pharmaceuticals, Inc. today announced BioSante’s receipt of Orphan Drug designation from the FDA’s Office of Orphan Products Development for GVAX Pancreas Vaccine in the treatment of pancreatic cancer.

More...

03-15-2010, 05:21 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,960	BioSante Pharmaceuticals receives receipt of Orphan Drug designation for GVAX Pancrea BioSante Pharmaceuticals, Inc. today announced BioSante’s receipt of Orphan Drug designation from the FDA’s Office of Orphan Products Development for GVAX Pancreas Vaccine in the treatment of pancreatic cancer. More...